1. "Clinical Genetics Service"
  2. "General Medicine Services"
  3. "Genitourinary Oncology Service"
  4. "Population Sciences Research Program"
  5. "2021"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Center for Pancreatic Cancer Research (8)
  2. Clinical Genetics Service (8)
  3. Department of Medicine (8)
  4. GSK Faculty (8)
  5. General Internal Medicine (8)
  6. General Medicine Services (8)

More Groups

People
  1. Alicia Latham (8)
  2. Diana Mandelker (8)
  3. Kenneth Offit (8)
  4. Maria Carlo (8)
  5. Michael Walsh (8)
  6. Yelena Kemel (8)

More People

Years
  1. 2021 (8)
Publications
  1. Journal of Clinical Oncology (2)
  2. Molecular Genetics and Metabolism (2)
  3. European Urology Oncology (1)
  4. JCO Precision Oncology (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Nature Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Academic Press (2)
  3. Elsevier BV (1)
  4. Nature Research (1)
  5. Oxford University Press (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing
    Journal Article

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Reisz, P. A.; Lenis, A. T.; Mehta, N. N.; Khurram, A.; Joseph, V.; Mandelker, D.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • Paired tumor-normal sequencing provides insights into the TP53-related cancer spectrum in patients with Li-Fraumeni syndrome
    Journal Article

    Ceyhan-Birsoy, O.; Selenica, P.; Chui, M. H.; Jayakumaran, G.; Ptashkin, R.; Misyura, M.; Aypar, U.; Jairam, S.; Yang, C.; Li, Y.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Disparities in pan-cancer patients undergoing germline cancer risk assessment by self-reported race/ethnicity and ancestry
    Meeting Abstract

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Fleischut, M. H.; Latham, A.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management
    Meeting Abstract

    Sheikh, R.; Truong, H.; Khurram, A.; Kemel, Y.; Vijay, J.; Mandelker, D.; Ceyhan-Birsoy, O.; Latham, A.; Walsh, M.; Liu, Y.; more...
    Molecular Genetics and Metabolism (2021)

    Fulltext@MSK | Save
  • Early-onset renal cell carcinoma: Assessment of germline genetic testing criteria
    Meeting Abstract

    Sheikh, R.; Truong, H.; Kotecha, R.; Kemel, Y.; Khurram, A.; Vijay, J.; Mandelker, D.; Ceyhan-Birsoy, O.; Latham, A.; Walsh, M.; more...
    Molecular Genetics and Metabolism (2021)

    Fulltext@MSK | Save
  • Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population
    Journal Article

    Salo-Mullen, E. E.; Maio, A.; Mukherjee, S.; Bandlamudi, C.; Shia, J. R.; Kemel, Y.; Cadoo, K. A.; Liu, Y.; Carlo, M.; Ranganathan, M.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save